Navigation Links
PRA International Participating in Pharmacoeconomics and Outcomes Research Conference
Date:5/15/2009

RALEIGH, N.C., May 15 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, announces it will exhibit at the annual meeting for the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), May 18-20 in Orlando, Florida. Experts from PRA's Late Phase Services group will be present in Booth 19 at ISPOR to discuss PRA's capabilities.

PRA's Late Phase Services group supports global and regional Post-Approval studies. With many years experience managing late phase studies ranging in size from 60 to 18,000 patients in over 40 countries, our international management team leads a truly global late phase team with centralized locations in Horsham, PA and Mannheim, Germany. PRA supports our Late Phase Services operational team with industry-leading strategic, scientific, medical and epidemiological experts.

To coordinate a meeting with PRA at ISPOR or for information on our upcoming audio conference, Blending REMS Science & Operational Execution, please contact David Fineza via email at finezadavid@praintl.com .

About PRA International

PRA International is a global Clinical Research Organization providing services through all phases of clinical development. We perform studies in all therapeutic areas, with specialization in Oncology, Neurosciences, Respiratory/Allergy, Cardiovascular and Infectious Diseases. PRA has supported over 2,100 clinical trials through its 35 global offices. PRA's therapeutic expertise, global reach and project experience, combined with extensive local knowledge and our differentiating PERSONAL ELEMENT enable our project teams to deliver consistent and on time performance for our clients. This unique PRA philosophy - THE PERSONAL ELEMENT - recognizes that true client service comes only from trained, empowered and dedicated employees who are encouraged to use innovation and their personal commitment to accelerate the development lifecycle.

To learn more about PRA International, please visit http://www.prainternational.com, email endpoints@praintl.com or call our Global Headquarters at +1 (919) 786-8200.


'/>"/>
SOURCE PRA International
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Spherix to Exhibit at the BIO 2009 International Convention
2. BioMS Medical to participate in panel session at Bio International Convention 2009
3. Kibow Biotech, Inc. to Present at BIO 2009 International Convention: Innovations to Heal, Fuel, and Feed the World
4. PAREXEL Consulting Experts To Present Insights Into Achieving Regulatory Approval at the 2009 BIO International Convention
5. Cell Therapeutics, Inc. (CTI) to Present at 2009 BIO International Convention
6. Boston Scientific to Donate Cardiac Rhythm Management Devices to Heartbeat International for Implantation in Needy Patients
7. Poniard Pharmaceuticals to Present at the 2009 BIO International Convention
8. BlueFire Ethanol To Present at BIO 2009 International Convention
9. GeoVax to Exhibit at the 2009 BIO International Convention
10. Yongye Biotechnology International Raises $ 9.0 Million In Private Placement, Raises Guidance
11. DATATRAK International, Inc. Forms Strategic Partnership with Inclinix, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... June 27, 2016  Global demand for enzymes ... through 2020 to $7.2 billion.  This market includes ... cleaning products, biofuel production, animal feed, and other ... and biocatalysts). Food and beverages will remain the ... increasing consumption of products containing enzymes in developing ...
(Date:6/27/2016)... NC (PRWEB) , ... June 27, 2016 , ... ... mission to bring innovative medical technologies, services and solutions to the healthcare market. ... and implementation of various distribution, manufacturing, sales and marketing strategies that are necessary ...
(Date:6/24/2016)... Epic Sciences unveiled a liquid biopsy ... PARP inhibitors by targeting homologous recombination deficiency (HRD) ... test has already been incorporated into numerous clinical ... Over 230 clinical trials are investigating ... PARP, ATM, ATR, DNA-PK and WEE-1. Drugs targeting ...
(Date:6/23/2016)...   Boston Biomedical , an industry leader ... target cancer stemness pathways, announced that its lead ... Designation from the U.S. Food and Drug Administration ... gastroesophageal junction (GEJ) cancer. Napabucasin is an orally ... stemness pathways by targeting STAT3, and is currently ...
Breaking Biology Technology:
(Date:6/20/2016)... -- Securus Technologies, a leading provider of civil ... investigation, corrections and monitoring announced that after exhaustive ... the final acceptance by all three (3) Department ... (MAS) installed. Furthermore, Securus will have contracts for ... October, 2016. MAS distinguishes between legitimate wireless device ...
(Date:6/9/2016)... June 9, 2016  Perkotek an innovation leader in attendance control systems is proud ... work hours, for employers to make sure the right employees are actually signing in, ... ... ... ...
(Date:6/3/2016)... June 3, 2016 ... Nepal hat ein ... hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, Registrierung und ... der Produktion und Implementierung von Identitätsmanagementlösungen. Zahlreiche ... im Januar teilgenommen, aber Decatur wurde als ...
Breaking Biology News(10 mins):